Privatlivspræferencer
Inderes bruger cookies for at give en bedre brugeroplevelse og en personlig service. Ved at give samtykke til brugen af cookies kan vi udvikle en endnu bedre service og vil kunne levere indhold, der er interessant for dig.
  • Forum
  • Aktiemarkeder
    • MarkederRealtidskurser, indekser og markedsudvikling
    • BørskalenderKommende resultater, noteringer og virksomhedsbegivenheder
    • UdbyttekalenderKommende og tidligere udbytter
  • Selskaber
    • SelskaberGennemse og filtrer den fulde liste over børsnoterede selskaber
    • OpdagInspiration til din næste investering
    • BørsnoteringerNye noteringer og kommende børsintroduktioner
    • Invitationer til generalforsamlingerDatoer for generalforsamlinger og aktionærinformation
  • Aktieanalyse
    • ResearchEkspertaktieanalyse og anbefalinger
    • ArtiklerNyheder, indsigter og markedskommentarer
    • inderesTVVideocenter for aktieanalyse, forskning og ekspertkommentarer
    • TransskriptionerFuldstændige udskrifter af resultatopkald og investormøder
    • AktieoversigtSammenlign nøgletal og udvikling på tværs af flere aktier
    • Earnings SeasonCompare EPS estimates to reported results
    • Compound Interest CalculatorSee how your savings grow with the power of compound interest.
Find os på de sociale medier
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Tag kontakt
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • Om os
  • Vores team
  • Karriere
  • Inderes som en investering
  • Tjenester for børsnoterede virksomheder
Vores platform
  • FAQ
  • Servicevilkår
  • Privatlivspolitik
  • Disclaimer

Inderes’ ansvarsfraskrivelse kan findes her. Detaljeret information om hver aktie, der aktivt overvåges af Inderes og HC Andersen Capital, er tilgængelig på de virksomhedsspecifikke sider på Inderes' hjemmeside. © Inderes Oyj. All rights reserved.

Cavotec: Low-margin legacy orders weigh on Q2 - ABG

CCCEksterne analyser24.07.2026, 14.57

Dette er en ekstern analyse og afspejler ikke nødvendigvis vores perspektiv eller værdier

Download analyse (PDF)
Q2: Sales of EUR 45m (36m), adj. EBIT of -EUR 1.1m (-0.7m)* P&M drives book-to-bill of 1.2x (R12m)
* Upbeat outlook commentary

Growth delivers, mix weighs
Cavotec reported sales above expectations at EUR 45m, +25% y-o-y (20% vs ABGSCe). P&M: 34% y-o-y, Industry: 12% y-o-y. Similar to in Q1, there was a strong order intake of EUR 49m (11% y-o-y), which was broadly as we expected following the pre-announcement, but it had not been incorporated into our estimates (ABGSCe 36m), as it was announced after our preview was published. With the R12m book-to-bill standing at ~1.2x, we see a healthy demand outlook for P&M. Adj. EBIT was softer than expected at EUR -1.1m vs ABGSCe of EUR 3.5m, with management attributing the adverse mix effects to deliveries of low-margin P&M orders dating back to 2024. NRIs of EUR -1.1m (ABGSCe -2.0m) were incurred in the quarter, relating to restructuring costs under the ongoing cost-savings programme.

'26e adj. EBIT lowered on earnings miss
We raise sales by 5%/4%/4% for '26e/'27e/'28e due to the revenue beat in the quarter. The strong order momentum for its shore power solutions de-risks our sales growth in '27-'28e. However, '26e adj. EBIT is lowered ~EUR 4.6m on the miss in the quarter, while we lower by another EUR 3.8m for the remaining two quarters of the year. We expect a sequential return to earnings growth in Q3, as the delivery of motorised cables and hose reels will be delivered to a ship unloader. Importantly, the outlook commentary marks a step-change, with management noting that customers are placing orders again after a long period of hesitancy.

15-10x '27e-'28e EV/EBIT
While profitability continued to trail revenue growth in the quarter, we see potential in an increasing backlog with a higher margin profile. However, we believe that some patience is required, as we expect earnings growth to return in '27e. The share is currently trading at 15-10x EV/EBIT on '27e-'28e, vs the peer median of 14-13x.